Question 1

How many shares of MGX does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 257,631 shares of MGX (METAGENOMI THERAPEUTICS INC).

Question 2

What is BlackRock, Inc.'s MGX position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s MGX position is worth $306,581.

Question 3

Is BlackRock, Inc. buying or selling MGX?

Accepted Answer

In 2026-Q2, BlackRock, Inc. increased their MGX position (+11.9% change in shares).

Question 4

When did BlackRock, Inc. first buy MGX?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in MGX in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	257,631	+11.9%	$306,581	0.0%	$1.19	18
2026-Q1	Increased	230,134	+2.7%	$308,379	0.0%	$1.51	16
2025-Q4	Increased	224,141	+0.3%	$363,108	0.0%	$1.60	16
2025-Q3	Decreased	223,451	-24.6%	$529,579	0.0%	$2.30	0
2025-Q2	Decreased	296,364	-80.8%	$438,618	0.0%	$1.46	0
2025-Q1	Increased	1.5M	+6.9%	$2.1M	0.0%	$1.48	19
2024-Q4	New	1.4M	-	$5.2M	0.0%	$3.52	37

MGX7 quarters

MGX
7 quarters